Dennis Mulroy - May 22, 2024 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Signature
/s/ Eric Loumeau, Attorney-in-Fact
Stock symbol
ANAB
Transactions as of
May 22, 2024
Transactions value $
-$35,580
Form type
4
Date filed
5/24/2024, 04:12 PM
Previous filing
Feb 1, 2024
Next filing
Jul 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Sale -$35.6K -1.5K -60.88% $23.72 964 May 22, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2023.
F2 Includes shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan, for the purchase period through May 15, 2024.